BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1163503)

  • 61. ADHD, autism and neuroradiological complications among phenylketonuric children in Upper Egypt.
    Saad K; Elserogy Y; Abdel Rahman AA; Al-Atram AA; Mohamad IL; ElMelegy TT; Bjørklund G; El-Houfy AA
    Acta Neurol Belg; 2015 Dec; 115(4):657-63. PubMed ID: 25576444
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcome at age 4 years in offspring of women with maternal phenylketonuria: the Maternal PKU Collaborative Study.
    Waisbren SE; Hanley W; Levy HL; Shifrin H; Allred E; Azen C; Chang PN; Cipcic-Schmidt S; de la Cruz F; Hall R; Matalon R; Nanson J; Rouse B; Trefz F; Koch R
    JAMA; 2000 Feb; 283(6):756-62. PubMed ID: 10683054
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Serum tyrosine in children with phenylketonuria and mild hyperphenylalaninemia].
    Cabalska B; Nowacka M; Laskowska-Klita T; Nowaczewska I; Zorska K; Taljański W
    Med Wieku Rozwoj; 2000; 4(1):5-12. PubMed ID: 11013857
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Disease course in 20 patients with an early diagnosis of phenylketonuria and hyperphenylalaninemia].
    Schwarz HP; Plüss C; Triaca H; Schütz B; Kaufmann R; Scherz R; Bachmann C; Zuppinger K
    Schweiz Med Wochenschr; 1988 Jan; 118(3):94-9. PubMed ID: 3344414
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phenylketonuria, co-morbidity, and ageing: A review.
    Vardy ERLC; MacDonald A; Ford S; Hofman DL
    J Inherit Metab Dis; 2020 Mar; 43(2):167-178. PubMed ID: 31675115
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnosis of phenylalanine hydroxylase deficiency (phenylketonuria).
    Berry HK; Hsieh MH; Bofinger MK; Schubert WK
    Am J Dis Child; 1982 Feb; 136(2):111-4. PubMed ID: 7064923
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Electroencephalogram evaluation of hyperphenylalaninemia patients on dietetic treatments].
    Wang KD; Cui G; Shen M
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2217-9. PubMed ID: 24169333
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU).
    Koletzko B; Beblo S; Demmelmair H; Hanebutt FL
    J Pediatr Gastroenterol Nutr; 2009 Mar; 48 Suppl 1():S2-7. PubMed ID: 19214054
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term follow-up of children with classical phenylketonuria after diet discontinuation: a review.
    Potocnik U; Widhalm K
    J Am Coll Nutr; 1994 Jun; 13(3):232-6. PubMed ID: 8077570
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Results of treatment and termination of the diet in phenylketonuria (PKU).
    Kang ES; Sollee ND; Gerald PS
    Pediatrics; 1970 Dec; 46(6):881-90. PubMed ID: 5491442
    [No Abstract]   [Full Text] [Related]  

  • 71. [Clinico-electroencephalographic evaluation of the effectiveness of diet therapy in patients with phenylketonuria].
    Ladado KS; Lebedev BV; Rybakova EP; Fateeva EM; Bliumina MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(10):1459-64. PubMed ID: 4660420
    [No Abstract]   [Full Text] [Related]  

  • 72. Sleep patterns in hyperphenylalaninemia: a lesson on serotonin to be learned from phenylketonuria.
    Schulte FJ; Kaiser HJ; Engelbart S; Bell EF; Castell R; Lenard HG
    Pediatr Res; 1973 Jun; 7(6):588-99. PubMed ID: 4350781
    [No Abstract]   [Full Text] [Related]  

  • 73. Dietary glycemic index, glycemic load and metabolic profile in children with phenylketonuria.
    Moretti F; Pellegrini N; Salvatici E; Rovelli V; Banderali G; Radaelli G; Scazzina F; Giovannini M; Verduci E
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):176-182. PubMed ID: 28081989
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Neuropsychiatric study on the effects of low-phenylalanine diet in phenylketonuria. 1. Electroencephalography, convulsions, developmental index and associated personality changes with low-phenylalanine diet therapy for phenylketonuria].
    Araki M
    Nihon Shonika Gakkai Zasshi; 1966 Nov; 70(11):1163-77. PubMed ID: 6008719
    [No Abstract]   [Full Text] [Related]  

  • 75. Phenylketonuria and complex spatial visualization: an analysis of information processing.
    Brunner RL; Berch DB; Berry H
    Dev Med Child Neurol; 1987 Aug; 29(4):460-8. PubMed ID: 3678625
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Psychosocial aspects of the treatment of phenylketonuria].
    Schweitzer S; Wolff G; Brodehl J
    Klin Padiatr; 1987; 199(2):90-4. PubMed ID: 3586565
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Treatment and control of patients with phenylketonuria: results from the Collaborative Group of Spanish Follow-up Units].
    Campistol J; González MJ; Gutiérrez AP; Vilaseca MA;
    Med Clin (Barc); 2012 Mar; 138(5):185-91. PubMed ID: 21794880
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A neuropsychological profile of off-diet adults with phenylketonuria.
    Moyle JJ; Fox AM; Bynevelt M; Arthur M; Burnett JR
    J Clin Exp Neuropsychol; 2007 May; 29(4):436-41. PubMed ID: 17497567
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
    Didycz B; Lemańska D; Słuszniak A
    Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.